Page last updated: 2024-09-03

imatinib mesylate and Angiitis

imatinib mesylate has been researched along with Angiitis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nagashima, H; Nakamura, Y; Sasaki, N; Sawai, T; Suzuki, N; Utsumi, Y; Yamashita, M; Yamauchi, K1
Bloomfield, K; Braunschweig, I; Chadburn, A; Darji, J; Gotlib, V; Patel, A1
Gross, WL; Hellmich, B; Holl-Ulrich, K1
Birck, R; Hochhaus, A; Kälsch, AI; Schmitt, WH; Soboletzki, M; van der Woude, FJ; Yard, BA1

Reviews

2 review(s) available for imatinib mesylate and Angiitis

ArticleYear
Eosinophilic variant of chronic myeloid leukemia with vascular complications.
    Leukemia & lymphoma, 2003, Volume: 44, Issue:9

    Topics: Adult; Anticoagulants; Antineoplastic Agents; Benzamides; Bone Marrow; Diagnostic Errors; Eosinophilia; Fingers; Gangrene; Humans; Imatinib Mesylate; Leg; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Pain; Piperazines; Pyrimidines; Radiography; Vasculitis; Vitamins

2003
[Hypereosinophilic syndrome--recent developments in diagnosis and treatment].
    Deutsche medizinische Wochenschrift (1946), 2007, Volume: 132, Issue:37

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Glucocorticoids; Humans; Hypereosinophilic Syndrome; Hypersensitivity; Imatinib Mesylate; Immunosuppressive Agents; Interferon-alpha; Lung Diseases; Neoplasms; Parasitic Diseases; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Tumor Necrosis Factor-alpha; Vasculitis

2007

Other Studies

2 other study(ies) available for imatinib mesylate and Angiitis

ArticleYear
Effects of imatinib mesylate on pulmonary allergic vasculitis in a murine model.
    International journal of rheumatic diseases, 2013, Volume: 16, Issue:4

    Topics: Administration, Inhalation; Administration, Oral; Animals; Benzamides; Bronchoalveolar Lavage Fluid; Cell Proliferation; Comorbidity; Cytokines; Disease Models, Animal; Eosinophils; Female; Imatinib Mesylate; Mice; Mice, Inbred C57BL; Myofibroblasts; Ovalbumin; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Respiratory Hypersensitivity; Vasculitis

2013
Imatinib mesylate, a new kid on the block for the treatment of anti-neutrophil cytoplasmic autoantibodies-associated vasculitis?
    Clinical and experimental immunology, 2008, Volume: 151, Issue:3

    Topics: Aged; Antibodies, Antineutrophil Cytoplasmic; Autoimmune Diseases; Benzamides; Cell Proliferation; Cells, Cultured; Culture Media, Conditioned; Cytokines; Drug Evaluation, Preclinical; Endothelium, Vascular; Granulomatosis with Polyangiitis; HLA-DR Antigens; Humans; Imatinib Mesylate; Lymphocyte Activation; Middle Aged; Piperazines; Protein Kinase Inhibitors; Pyrimidines; T-Lymphocytes; Vasculitis

2008